SGLT2 Inhibitors, GLP-1 Agonists, and DPP-4 Inhibitors in Diabetes and Microvascular Complications: A Review

Figure 1

Mechanism of action of diabetes medications on multiple organ systems: (a) SGLT2 inhibitors [1]; (b) DPP-4 inhibitors [2]; (c) GLP-1 agonists [3].

(a)

(b)

(c)